Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 25Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cosette Pharma Launches Generic CIPRO HC With (CGT) Exclusivity
    Cosette Pharma Launches Generic CIPRO HC With (CGT) Exclusivity

    16 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251216065234/en/Cosette-Pharmaceuticals-Announces-the-Approval-and-Launch-of-First-Generic-Version-of-CIPRO-HC-ciprofloxacin-0.2-HCl-and-hydrocortisone-1-otic-suspension-with-180-days-Competitive-Generic-Therapy-CGT-exclusivity

    BUSINESSWIRE
    16 Dec 2025
    Share Share
    Enforcement Report - Week of September 17, 2025
    Enforcement Report - Week of September 17, 2025

    17 Sep 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-17-2025-5582.pdf

    FDA
    17 Sep 2025
    Share Share
    Enforcement Report - Week of April 23, 2025
    Enforcement Report - Week of April 23, 2025

    23 Apr 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-23-2025-55577.pdf

    FDA
    23 Apr 2025
    Share Share
    Enforcement Report - Week of March 26, 2025
    Enforcement Report - Week of March 26, 2025

    26 Mar 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-26-2025-60230.pdf

    FDA
    26 Mar 2025
    Share Share
    Enforcement Report - Week of January 15, 2025
    Enforcement Report - Week of January 15, 2025

    15 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-15-2025-7287.pdf

    FDA
    15 Jan 2025
    Share Share
    IdentiRx`s Generics Ciprofloxacin HCl Receives Approval in US
    IdentiRx`s Generics Ciprofloxacin HCl Receives Approval in US

    05 Nov 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217887

    FDA
    05 Nov 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.